Vegetable-based drug can inhibit melanoma: US researchersMarch 2nd, 2009 - 5:32 am ICT by IANS
Washington, March 2 (Xinhua) Compounds extracted from green vegetables such as broccoli and cabbage could be a potent drug against melanoma, according to US cancer researchers.
Tests on mice suggest that these compounds, when combined with selenium, target tumours more safely and effectively than conventional therapy.
“There are currently no drugs to target the proteins that trigger melanoma,” said Gavin Robertson, associate professor of pharmacology, pathology and dermatology, Penn State College of Medicine. “We have developed drugs from naturally occurring compounds that can inhibit the growth of tumors in mice by 50 to 60 percent with a very low dose.”
Robertson and his colleagues previously showed the therapeutic potential of targeting the Akt3 protein in inhibiting the development of melanoma. The search for a drug to block the protein led them to a class of compounds called isothiocyanates.
These naturally occurring chemicals found in cruciferous vegetables are known to have certain cancer-fighting properties. However, the potency of these compounds is so low that a successful drug would require large impractical amounts of these compounds.
Instead, the Penn State researchers rewired the compounds by replacing their sulphur bonds with selenium. The result, they believe, is a more potent drug that can be delivered intravenously in low doses.
“Selenium deficiency is common in cancer patients, including those diagnosed with metastatic melanoma,” explained Robertson, whose findings appear in the March edition of Clinical Cancer Research. “Besides, selenium is known to destabilize Akt proteins in prostate cancer cells.”
To study the effectiveness of the new drug - isoselenocyanate - researchers injected mice with 10 million cancer cells. Six days later, when the animals developed large tumours, they were divided into two groups and treated separately with either the vegetable compounds or the compounds supplemented with selenium.
“We found that the selenium-enhanced compounds significantly reduced the production of Akt3 protein and shut down its signaling network,” explained Robertson, who is also associate director of translational research and leader of the experimental therapeutics program at Penn State Hershey Cancer Institute. The modified compounds also reduced the growth of tumors by 60 percent, compared to the vegetable-based compounds alone.
When the researchers exposed three different human melanoma cell lines to the two compounds, the selenium-enhanced drug worked better on some cell lines than others. The efficiency was from 30 to 70 percent depending on the cell line.
The exact mechanism of how selenium inhibits cancer remains unclear. However Robertson, who has a filed provisional patent on the discovery, is convinced that the use of naturally occurring compounds that target cancer-causing proteins could lead to more effective ways of treating melanoma.
“We have harnessed something found in nature to target melanoma, ” said Robertson. “And since we only need tiny amounts to kill the cancer cells, it means even less toxic side-effects for the patient.”
Human trials of the new drug are still some years away, but the Penn State researcher envisions a drug that could be delivered either intravenously to treat melanoma, or added to sunscreen lotion to prevent the disease.
- Broccoli and brussels sprouts boost sunscreens' cancer fighting abilities - Apr 27, 2011
- Broccoli, cabbage can help fight skin cancer - Mar 02, 2009
- Targeting protein helps keep melanoma tumour growth in check - Dec 10, 2010
- Melanoma spreads to lungs using body's immune system - Oct 08, 2010
- Nanotechnology may lead to new liver cancer treatment - Feb 23, 2011
- Indian-origin scientist's finding offers hope for advanced cancer patients - Apr 06, 2011
- Synthetic compound may lead to drugs to fight pancreatic, lung cancer - Mar 10, 2011
- Motor protein that blocks ovarian tumor growth found - Apr 27, 2011
- Arthritis drug could help treat skin cancer - Mar 24, 2011
- Zebrafish offers skin cancer clues - Apr 06, 2011
- Sun-triggered protein 'makes skin cancer worse' - Feb 04, 2011
- New drug shrinks cancer, with few side effects - Apr 07, 2011
- Protein discovery could lead to better autoimmune disease, cancer drugs - Mar 03, 2011
- New discovery holds promise for liver cancer treatment - Mar 23, 2011
- Possible new treatment strategies for pancreatic cancer found - Mar 04, 2011
Tags: cancer patients, cancer researchers, clinical cancer research, college of medicine, compounds, conventional therapy, cruciferous vegetables, gavin robertson, green vegetables, melanoma, penn state college, penn state college of medicine, penn state researchers, potency, potent drug, prostate cancer, prostate cancer cells, target, tumours, xinhua